Medication info

Vibrown 0.45% Sodium Chloride Injection

Prescription medicationIntravenous injectionApproval withdrawn
Ingredient · strength
Sodium Chloride›0.45g / 100mL
Manufacturer / importer
B.Braun Korea Co., Ltd
Appearance
Colorless and transparent injection in a plastic container
Packaging
Bottle - 500 milliliters/bottle
Approval status
Approval withdrawn

MFDS item code 200308131 · Notified 2003.05.23

This product's status changed to Approval withdrawn on 2024.12.13. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Dissolution and dilution of injectable drugs; improvement of water and electrolyte deficiencies
Who receives it
Adults
Adult administration
Usually, 20~1,000mL as sodium chloride is administered subcutaneously, intravenously, by intravenous infusion, or rectally. Adjust the dose and rate of administration as appropriate according to age, body weight, and symptoms. Use an appropriate amount for dissolving and diluting the injectable preparation.

Ingredients

Importer
B.Braun Korea Co., Ltd

Efficacy & effects

Dissolution and dilution of injectable drugs; improvement of water and electrolyte deficiencies

  • Water deficiency
  • electrolyte deficiency
  • sodium deficiency
  • chloride deficiency
View approved original text

This medication is used to replenish water and electrolytes when they are deficient, especially sodium and chloride. It is also utilized for diluting or dissolving injectable medications. This helps to balance the body and improve health.

How it is given

Adult administration

Usually, 20~1,000mL as sodium chloride is administered subcutaneously, intravenously, by intravenous infusion, or rectally. Adjust the dose and rate of administration as appropriate according to age, body weight, and symptoms. Use an appropriate amount for dissolving and diluting the injectable preparation.

Precautions

This medication can introduce glass particles when opening the container, so care must be taken, especially when used for children or the elderly. This medication should not be used in patients with hypernatremia, excessive body fluid, or liver cirrhosis accompanied by edema and ascites. It should be administered with caution in patients with impaired heart or circulatory function, renal problems, low protein levels in the blood, abnormal sodium or potassium levels, pulmonary edema, preeclampsia, those undergoing certain hormone therapies, as well as in children and the elderly. Administering this medication in excess or too rapidly can lead to side effects such as heart failure, edema, acidosis, and electrolyte imbalances. Infection, pain, inflammation, or thrombosis at the injection site may occur; therefore, if any abnormal symptoms arise, administration should be immediately stopped, and appropriate treatment should be sought. During the intravenous therapy period, the patient's fluid balance, electrolyte concentrations, and acid-base status should be regularly monitored to observe their condition closely. The plasticizer (DEHP) used in the PVC material of the container may affect genital development in animal studies, but the risk of not using this medication is greater, so there is no need for concern. Elderly patients may have decreased bodily functions, so the administration rate should be slow, and dosages adjusted; children may have reduced ability to regulate fluid and electrolytes, which requires careful monitoring of blood electrolyte levels. In particular, administering this medication during acute fluid deficiency in children may lead to hyponatremia, which can cause headaches, nausea, seizures, coma, cerebral edema, and in severe cases, death, requiring rapid emergency response. Before administration, check for discoloration, precipitates, or insoluble substances in the solution, and ensure the administration site is properly disinfected. During cold conditions, warm the medication to body temperature before use, and any remaining medication after opening or mixing with other drugs should not be reused. Finally, this medication should be infused slowly to minimize the occurrence of side effects.

Side effects

  • congestive heart failure
  • edema
  • acidosis
  • serum electrolyte abnormalities
  • fever
  • infection at the injection site
  • localized pain
  • local reactions
  • venous irritation
  • venous thrombosis
Show 10 more
  • phlebitis
  • extravasation
  • hypervolemia
  • headache
  • nausea
  • seizures
  • drowsiness
  • coma
  • cerebral edema
  • death

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture, and it is important to maintain storage temperatures between 1 and 30 degrees Celsius (room temperature). This will help to preserve the medication's potency and safety over time.

Appearance and packaging

Appearance

Colorless and transparent injection in a plastic container

Package unit

Bottle - 500 milliliters/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.